November 30, 2021 News by Marisa Wexler, MS Some Cell Therapies Work by Dying, New Research Shows Certain cell therapies that hold promise for treating autoimmune diseases like multiple sclerosis might work not because of the way the cells live in the body during treatment, but because of how they die. A better understanding of how these cell therapies work “is important in designing treatment protocols…
November 29, 2021 Columns by Ed Tobias MS News That Caught My Eye Last Week: Stem Cell Trial, COVID-19 Vaccines, MS Blood Test First Patient Dosed in Phase 1 Trial of IMS001 Therapy IMS001 is an investigational treatment that uses mesenchymal stem cells (MSC) ā cells derived from human embryos. Preclinical studies have shown that IMS001 has the ability to stabilize an overactive immune system, as is the case in people with…
November 23, 2021 News by Yedida Y Bogachkov PhD First Patient Dosed in Phase 1 Trial of IMS001 Therapy ImStem Biotechnology announced that the first patient in its Phase 1 clinical trial for IMS001, an investigational treatment for multiple sclerosis (MS), has been dosed at the Shepherd Center in Atlanta. The trial (NCT04956744) is recruiting participants with an MS diagnosis ages 18 to 65. More information…
July 28, 2021 News by Forest Ray PhD FDA Greenlights Stem Cells Trial Aiming to Improve Quality of Life The U.S. Food and Drug Administration (FDA) has given the green light to a Phase 2 clinical trial that will assess the efficacy of using adult mesenchymal stem cellsĀ (MSCs) to treat the symptoms of mild to moderateĀ multiple sclerosisĀ (MS). The non-profit Hope Biosciences Stem Cell Research Foundation (HBSCRF),…
February 26, 2019 News by Santiago Gisler Cleveland Clinic Chosen for Phase 2 Trial Testing NurOwn Stem Cell Therapy in Progressive MS Patients BrainStorm Cell Therapeutics announced theĀ Cleveland ClinicĀ is the first clinical site contracted in the United States for the Phase 2 multi-center study evaluating the companyās NurOwn mesenchymal stem cell (MSC) therapy in individuals with progressive multiple sclerosis (MS). āWe are very excited to announce The Mellen Center for…
December 19, 2018 News by Alberto Molano, PhD FDA Gives Green Light to Phase 2 Trial of NurOwn Stem Cell Therapy in Progressive MS Patients The U.S. Food and Drug Administration (FDA) has approvedĀ BrainStorm Cell Therapeutics‘ request to open a Phase 2 clinical trial testing the safety and effectiveness of its proprietary NurOwn mesenchymal stem cell (MSC)Ā treatment inĀ progressive multiple sclerosis (MS) patients. The request was in the form of Investigational New Drug…
June 3, 2016 News by Patricia Silva, PhD #CMSC16 – Stem Cell Therapy in MS: Exclusive Interview with Dr. Mark Freedman On June 2, a symposium titled “Cell-based therapies in MS” was presented at theĀ 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers (CMSC). One of the speakers was Dr.Ā Mark S. Freedman, professor of medicine (neurology) at the University of OttawaĀ inĀ Canada, who discussed the use of stem…
July 18, 2014 News by Patricia Silva, PhD Startup ImStem Raising Funds For Novel Stem-Cell MS Treatment Startup biotech company ImStem BiotechnologyĀ is looking to raise additional funding for their upcoming clinical trials after publishing promising research on a unique stem-cellĀ treatment used on mice withĀ multiple sclerosis. Ā The company has already received previous funding…